Exchange: NYSE·Updated 09:00 PM EST

ENOV News

News
all
press releases
Enovis (NYSE:ENOV) Director Purchases $24,877.60 in Stock
Enovis Corporation (NYSE:ENOV - Get Free Report) Director Angela Lalor acquired 880 shares of Enovis stock in a transaction that occurred on Friday, November 13th. The stock was acquired at an average cost of $28.27 per share, with a total value of $24,877.60. Following the purchase, the director...
MarketBeat
Enovis (NYSE:ENOV) Director Purchases $24,877.60 in Stock
Enovis Corporation (NYSE:ENOV - Get Free Report) Director Angela Lalor acquired 880 shares of Enovis stock in a transaction that occurred on Friday, November 13th. The stock was acquired at an average cost of $28.27 per share, with a total value of $24,877.60. Following the purchase, the director...
MarketBeat
More News
Enovis Corporation (NYSE:ENOV - Get Free Report) Director Angela Lalor acquired 874 shares of the stock in a transaction that occurred on Thursday, November 12th. The stock was purchased at an average price of $28.04 per share, for a total transaction of $24,506.96. Following the completion of the...
MarketBeat
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets
Enovis (ENOV) delivered earnings and revenue surprises of +15.79% and +0.56%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Innoviva (INVA) delivered earnings and revenue surprises of +2.04% and -6.89%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Enovis becomes first multi-registry industry sponsor of AAOS Registry Program Enovis becomes first multi-registry industry sponsor of AAOS Registry ProgramPR NewswireROSEMONT, Ill., Sept. 22, 2026 Company expands its support from the American Joint Replacement Registry to include the Shoulder...
PR Newswire
As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys. At Enovis, a filing with the SEC revealed that on Friday, Chief Executive Officer D...
Nasdaq News: Markets
Enovis (ENOV) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks
Enovis (ENOV) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Zacks
ENOV is set to acquire eCential Robotics to expand into orthopedic surgical robotics, though the deal is expected to pressure 2027 margins.
Zacks

Advertisement|Remove ads.